Latest Ratios: P/E Ratio 34.0x · EV/EBITDA 13.3x · ROE 12.2%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.2B | $703M | $413M | $725M | $798M | $728M | $746M | $595M | $505M | $596M | $429M |
| Enterprise Value | $1.5B | $1.0B | $795M | $790M | $908M | $840M | $814M | $613M | $523M | $744M | $610M |
| P/E Ratio → | 34.01 | 20.13 | 58.11 | 14.81 | 13.55 | 21.75 | 20.37 | 24.53 | — | — | 476.67 |
| P/S Ratio | 1.44 | 0.85 | 0.49 | 0.89 | 0.89 | 0.96 | 1.46 | 1.15 | 0.89 | 1.09 | 0.77 |
| P/B Ratio | 4.04 | 2.39 | 1.49 | 2.48 | 3.11 | 3.48 | 3.95 | 3.57 | 3.27 | 6.36 | 4.61 |
| P/FCF | 17.68 | 10.46 | 7.53 | 11.45 | 16.52 | 26.90 | 22.56 | 13.51 | 9.00 | 15.43 | 20.22 |
| P/OCF | 13.69 | 8.10 | 5.21 | 8.42 | 10.99 | 16.20 | 16.05 | 10.95 | 8.25 | 13.41 | 12.71 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.26 | 0.95 | 0.97 | 1.01 | 1.10 | 1.59 | 1.19 | 0.92 | 1.36 | 1.09 |
| EV / EBITDA | 13.30 | 9.06 | 9.59 | 8.30 | 8.63 | 12.05 | 10.98 | 10.14 | 16.31 | 13.99 | 12.85 |
| EV / EBIT | 20.24 | 13.91 | 17.86 | 10.92 | 10.61 | 17.20 | 15.14 | 15.69 | 17.58 | 30.56 | 21.32 |
| EV / FCF | — | 15.43 | 14.48 | 12.48 | 18.78 | 31.05 | 24.59 | 13.93 | 9.32 | 19.27 | 28.78 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 33.4% | 33.4% | 32.4% | 31.9% | 31.6% | 27.9% | 33.7% | 33.2% | 31.6% | 28.8% | 29.5% |
| Operating Margin | 9.1% | 9.1% | 5.3% | 8.9% | 9.3% | 6.5% | 10.5% | 7.2% | 1.1% | 4.5% | 2.9% |
| Net Profit Margin | 4.2% | 4.2% | 0.9% | 6.0% | 6.7% | 4.4% | 7.2% | 4.7% | -0.6% | -1.8% | 0.2% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 12.2% | 12.2% | 2.5% | 17.8% | 25.9% | 16.8% | 20.7% | 15.1% | -2.7% | -10.6% | 1.1% |
| ROA | 4.1% | 4.1% | 1.0% | 9.0% | 11.7% | 7.6% | 9.8% | 6.9% | -1.0% | -2.7% | 0.3% |
| ROIC | 8.8% | 8.8% | 6.6% | 15.0% | 18.3% | 12.8% | 18.2% | 15.6% | 2.3% | 7.2% | 4.4% |
| ROCE | 10.8% | 10.8% | 8.2% | 18.5% | 22.2% | 16.2% | 20.3% | 14.3% | 2.5% | 8.9% | 5.3% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.29 | 1.29 | 1.49 | 0.33 | 0.52 | 0.62 | 0.51 | 0.56 | 0.50 | 1.61 | 2.04 |
| Debt / EBITDA | 3.31 | 3.31 | 4.99 | 1.00 | 1.26 | 1.87 | 1.29 | 1.56 | 2.39 | 2.84 | 3.99 |
| Net Debt / Equity | — | 1.13 | 1.38 | 0.22 | 0.43 | 0.54 | 0.36 | 0.11 | 0.12 | 1.58 | 1.95 |
| Net Debt / EBITDA | 2.92 | 2.92 | 4.61 | 0.68 | 1.04 | 1.61 | 0.91 | 0.31 | 0.56 | 2.79 | 3.82 |
| Debt / FCF | — | 4.96 | 6.96 | 1.03 | 2.26 | 4.16 | 2.04 | 0.42 | 0.32 | 3.85 | 8.57 |
| Interest Coverage | 2.53 | 2.53 | 1.44 | 11.40 | 14.93 | 11.60 | 10.98 | 7.99 | 4.83 | 2.82 | 2.89 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.67 | 1.67 | 1.76 | 1.55 | 1.87 | 1.66 | 1.29 | 2.24 | 1.88 | 1.52 | 1.78 |
| Quick Ratio | 1.16 | 1.16 | 1.10 | 1.00 | 1.19 | 0.95 | 0.83 | 1.70 | 1.43 | 1.04 | 1.20 |
| Cash Ratio | 0.27 | 0.27 | 0.22 | 0.18 | 0.17 | 0.13 | 0.20 | 0.91 | 0.60 | 0.03 | 0.10 |
| Asset Turnover | — | 0.97 | 0.97 | 1.50 | 1.66 | 1.57 | 1.28 | 1.46 | 1.63 | 1.54 | 1.46 |
| Inventory Turnover | 6.39 | 6.39 | 5.83 | 6.10 | 6.59 | 5.87 | 5.13 | 7.78 | 8.89 | 8.28 | 8.55 |
| Days Sales Outstanding | — | 55.39 | 53.26 | 57.75 | 54.26 | 49.47 | 60.61 | 44.18 | 50.13 | 59.79 | 43.49 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 1.7% | 2.9% | 4.9% | 2.8% | 2.5% | 2.7% | 2.6% | 3.2% | 3.5% | 2.7% | 3.8% |
| Payout Ratio | 58.7% | 58.7% | 283.7% | 41.4% | 32.8% | 58.4% | 52.8% | 79.4% | — | — | 1534.6% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 2.9% | 5.0% | 1.7% | 6.8% | 7.4% | 4.6% | 4.9% | 4.1% | — | — | 0.2% |
| FCF Yield | 5.7% | 9.6% | 13.3% | 8.7% | 6.1% | 3.7% | 4.4% | 7.4% | 11.1% | 6.5% | 4.9% |
| Buyback Yield | 0.2% | 0.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.1% | 0.0% |
| Total Shareholder Yield | 1.9% | 3.3% | 4.9% | 2.8% | 2.5% | 2.7% | 2.6% | 3.2% | 3.7% | 2.8% | 3.8% |
| Shares Outstanding | — | $38M | $37M | $37M | $36M | $36M | $36M | $36M | $33M | $31M | $30M |
Includes 30+ ratios · 30 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying MYE stock.
Myers Industries, Inc.'s current P/E ratio is 34.0x. The historical average is 20.3x. This places it at the 95th percentile of its historical range.
Myers Industries, Inc.'s current EV/EBITDA is 13.3x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 11.8x.
Myers Industries, Inc.'s return on equity (ROE) is 12.2%. The historical average is 7.2%.
Based on historical data, Myers Industries, Inc. is trading at a P/E of 34.0x. This is at the 95th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Myers Industries, Inc.'s current dividend yield is 1.73% with a payout ratio of 58.7%.
Myers Industries, Inc. has 33.4% gross margin and 9.1% operating margin.
Myers Industries, Inc.'s Debt/EBITDA ratio is 3.3x, indicating high leverage. A ratio between 2-4x is manageable but warrants monitoring.
Key Metrics
Top Statement Risk
High leverage and revenue decline
Metrics are mathematically derived from official filings.
Margin Recovery Masks Volume Weakness
Gross margin expanded to 36.4% in 2026Q2 from 33.2% in 2025Q4, while operating margin surged to 17.4%, per reported financials, yet revenue contracted 14.5% year-over-year, suggesting cost cuts rather than demand strength.
The sequential margin expansion is driven by aggressive SG&A reduction, which fell 38% from 2025Q4 to 2026Q2, as reported. This indicates that profitability improvements are largely cost-driven, not revenue-driven, and may not be sustainable if volume continues to decline. Investors should monitor whether margin gains can hold without further cost cuts.
Return on Capital Recovering from Cyclical Trough
ROIC improved to 3.9% in 2026Q2 from a negative -0.5% in 2024Q3, per financial statements, but remains well below the cost of capital, indicating that the company is still rebuilding earning power after a severe downturn.
The recovery in ROIC is driven by margin expansion and a shrinking asset base, as total assets declined with goodwill reductions. However, ROIC at 3.9% is still low relative to peers like Innospec (11.4%) and Silgan (8.7%), suggesting that capital efficiency has not fully normalized. The company's ability to generate returns above its cost of capital remains uncertain, especially if revenue continues to slide.
Working Capital Efficiency Improves but Remains Elevated
Cash conversion cycle shortened to 55 days in 2026Q2 from 75 days in 2024Q4, as reported, driven by faster receivables collection and lower inventory days, yet DSO at 55 days still indicates room for improvement versus historical norms.
The improvement in CCC is a positive sign, reflecting better working capital management, but the absolute level remains high, suggesting that the company still ties up significant cash in operations. DPO has remained relatively stable around 52-57 days, indicating limited supplier leverage. The reduction in DIO from 70 to 57 days may reflect lower inventory levels due to declining demand, which could reverse if sales recover.
Leverage Eases but Debt Burden Remains Heavy
Debt-to-EBITDA fell to 9.73x in 2026Q2 from 19.95x in 2025Q1, per reported figures, yet interest coverage of 4.97x remains thin, indicating that debt service is still a significant drag on earnings.
The deleveraging trend is encouraging, with total debt down 23.6% from 2024Q1, but the absolute level of leverage is still high relative to peers like Silgan (D/E 2.03) and Innospec (0.04). The improvement in D/EBITDA is partly due to EBITDA recovery, not just debt reduction. Interest coverage, while improved, is still below the 5x threshold that many analysts consider comfortable, leaving limited room for further earnings shocks.
Liquidity Buffer Modest but Stable
Current ratio of 1.61 in 2026Q2, as reported, provides a modest cushion, but quick ratio of 1.21 indicates that inventory is a significant component of current assets, which could be at risk if demand weakens further.
The liquidity position appears adequate for near-term obligations, but the reliance on inventory to meet current liabilities is a concern given the revenue decline. Cash of $47.6M provides some buffer, but it is not substantial relative to the company's debt load. Under a severe stress scenario, the company may need to draw on credit lines or reduce capex further, which could impact long-term competitiveness.
Misapplied Metric: P/E on Cyclical Earnings
The trailing P/E of 36.03, as reported, is misleading because it is based on depressed earnings from the cyclical trough; forward P/E of 18.02 better reflects normalized earnings, but even that may overstate value if revenue decline persists.
For a cyclical manufacturer like Myers, P/E ratios are distorted by the earnings cycle. The trailing P/E is artificially high due to low earnings in 2024Q3, while the forward P/E assumes a recovery that may not materialize. A more appropriate metric is EV/EBITDA, which at 13.91x is still above peers like Silgan (8.20x) and Innospec (9.97x), suggesting the market is pricing in a strong recovery. Investors should focus on EV/EBITDA and cash flow metrics, such as P/FCF at 18.73x, which is more stable across cycles.